Corvus Pharmaceuticals, Inc. · NASDAQ:CRVS
Richard A. Miller reported a 7.80% stake in Corvus Pharmaceuticals, Inc. (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 13, 2026
Richard A. Miller reported a 7.80% stake in Corvus Pharmaceuticals, Inc., 6,085,922 shares, as a passive investor on Dec 31, 2025. Filed Feb 13, 2026 (Schedule 13G/A).
- Stake
- 7.80%
- Shares
- 6,085,922
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Richard A. Miller | 7.80% | 6,085,922 |
| Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985 | 1.60% | 1,188,103 |
| Sandra J. Horning | 1.60% | 1,188,103 |
Source
Related
- Corvus Pharmaceuticals, Inc.
- Miller Richard A Md
- Corvus Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · Miller Richard A Md · Feb 13, 2025
- Schedule 13G · State Street Corp · Aug 7, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 27, 2026
- Form 4 · Moore David Scott · Jun 15, 2026
- Form 4 · Miller Richard A Md · May 20, 2026
- Schedule 13G · Sirenia Capital Management LP · May 15, 2026